The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical stages in the U.S. and China. Concurrently, the ...
AI tools are flooding health care. The speed of innovation, lax regulation means that many don't improve patient care, cost.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results